chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous prospective pregnancy report as received from a physician refers to a female patient of unknown age. The patient's history of previous pregnancies and live births is not known. The patient was vaccinated with a dose (lot # 1404AA, expiration date 13-SEP-2013) of M-M-R II (dose and route not reported) on 25-MAY-2012. No other co-suspects were reported. No concomitant medications were reported. The physician reported that the patient received the vaccines when she was 3-4 weeks pregnant. The LMP was approximately in April 2012 and an EDD of approximately February 2013. Initial exposure to M-M-R II was at 3-4 weeks during trimester 1. The patient experienced no adverse symptoms. No treatment information was reported. At the time of the report the outcome of pregnancy was unknown. Additional information has been requested.
Heart palpitations, muscle spasms, weak lethargic and tired, joint/muscle pain, headaches, slight fever (99.2).  Took ibuprofen for treatment and slept the next day.
Client felt lightheaded and "palpitations" approximately 10-15 min post injection. States palpitations occurred two more times. She notified her doctor and I gave her Benadryl 50 mg by mouth.
Severe vertigo -- could not walk. Saw ENT and was diagnosed with vestibular neuritis. Associated vomiting.
Information has been received from a consumer concerning her son with no known drug allergies and no past medical history and a recent varicella exposure who in approximately 1998 was vaccinated with varicella vaccine. There was no concomitant medication. On 06/15/2001, two weeks after he was exposed, the pt became cranky and developed a low fever. He had a mild breakout of lesions on his back, groin and a few on his face. The major symptoms resolved in 2-3 days and the lesions formed scabs in that time period. Unspecified medical attention was sought. It was noted that the pt's sister had a similar experience after vaccination with varicella vaccine and subsequent exposure to chicken pox. The pt's mother noted that varicella is "spreading wildly through their community." Follow-up info has been received from a physician indicating that the pt did not go to the office for evaluation. The physician also indicated that the vaccine was given in 1998 but not at that office. Additional info has been requested.
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 26-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 10-Nov-2021. On 05-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). On 05-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Blood test: normal (normal) normal. On 07-Apr-2021, Glucose tolerance test: normal (normal) normal. On 07-Apr-2021, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication is provided. Treatment information was not provided.  The patient's estimated date of conception was 20-Feb-2021.
Initial report received from Healthcare Professional on 10 May 2012. A male patient (Age not reported), whose medical history and concomitant medications were not reported, had received a intramuscular dose of ADACEL vaccine (lot number- not reported and site of administration- not reported) and Intramuscular dose of MENACTRA vaccine (lot number- not reported and site of administration- not reported) on in unspecified date in May 2007. Shortly after vaccination, the patient experienced tingling in shoulder, headache, vomiting, fever, weakness in legs and couldn't get up of couch. The symptoms lasted for 24 hours and then mostly resolved. The patient was seen by physician and diagnosed with exacerbation of migraine. The patient had a follow up appointment with doctor for 27 August 2007 and never came back. The relevant diagnosis reported as none. The outcome of events was reported as recovered. Documents held by sender: none.
Patient was in waiting room immediately following vaccine and got up to briskly walk to restroom, at which time patient reports feeling very hot (~2 minutes after vaccine administration) and went to bathroom to get cold water. Patient came back to waiting area and sat down and then vomited in the chair. Pharmacist walked over to patient to ask how they were feeling and offered water. Patient reported that they remember feeling very hot and getting up to splash water on face. Patient stated "oh wow, I must have gotten sick" indicating they had no recollection of that. The patient reported feeling fine following the episode and stayed in the waiting room for 30 minutes. Patient was advised to go to urgent care to be checked for further evaluation.
Pain, tightness in left side of jaw, beginning approximately 10 minutes after injection. Continued to wait at the pharmacy and spoke to the pharmacist after she finished administering other shots. She asked if there was any difficulty breathing, which there was not. She suggested waiting another 10?15 minutes to ensure no other symptoms occurred. Jaw tightness continued for a few hours but was mostly gone by the next morning.
woke up from sleep d/t diff breathing-wheezing, sore throat, nose running, made sounds from chest wheezing tingling to get air 250AM shaking from chills;330AM running temp;545AM t100.8;took ASA; eyes (white part) were pink;
Information has been received from a licensed practical nurse concerning a 12 month old white female patient with no known allergies who on 24-Mar-2003 at 11 was vaccinated subcutaneously in the left thigh with a first dose of varicella virus vaccine live (Lot #644032/1059M). Concomitant vaccination included a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). There was no other concomitant medication. Two to three days post vaccination on approximately 26-Mar-2003, the patient developed "break through chickenpox" with a low grade fever and a small pox-like rash at the injection site. The patient sought medical attention and was treated with prescription diphenhydramine and acetaminophen (APAP). Follow-up information indicated that the patient developed a diffuse red rash with a low grade fever on 03-Apr-2003 at 15:15, ten days after the vaccine. It was noted that the patient was anxious. The reporter stated that this "also may be due to [measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)]". The reporter stated that there was no "clinically significant adverse event" and it was cleared in a few days. It was noted that the patient recovered from the diffuse red rash with a low grade fever. The reporter also mentioned a second patient that developed break through chickenpox post vaccination with a dose of varicella virus vaccine live (Lot #644032/1059M) (WAES #0304USA01917). Additional information is not expected.
rawness on lt leg;raised, whelps, burning;pt applied an anti-itch cream & applied tissue-pain;describes as hives;
Fatigue, vertigo, night sweats, severe pain at 10/10 from C-7, T-1, radiating down L arm and to 4-3rd fingertips. After two rounds of steroids pain is still disabling as is provoked with chin tilt. Have fine motor weakness L hand.
This is a spontaneous report from a contactable physician via a Pfizer sales representative. A female patient of an unspecified age (Age: 18, Unit: Unknown) received TRUMENBA, (lot number: S85201, expiration date: 32Dec2019) via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient was given meningococcal group b rlp2086 in the lab and fainted at check out. It was reported that the patient wasn't acting right at home and was brought back in. The outcome of fainted and wasn't acting right at home was unknown.
Information has been received from a physician concerning a 12 year old female who on 11-MAY-1998 and 01-AUG-2001 was vaccinated with the first and second doses of MMR II, respectively. On 17-NOV-2009 the patient experienced mumps. At the time of the report, the patient's outcome was unknown. No further information is available.
Patient woke up around 3:30am feeling extremely nauseous, shaking, drenched in sweat but with a normal temperature (97.6, which is normal for him), and feeling overall terrible.  Food had tasted weird to him the day before, but he still ate. At 3:30am, he felt like he was having a major allergy attack - lots of phlegm, runny nose and eyes. He spit up a lot of thick phlegm (which can be normal for him, due to IBM). After 15 mins, the sweat and shaking died down, and he felt better enough to think about going to sleep. But 5 minutes later, the nausea returned, and he threw up about 25 mL of black "coffee grounds-like" fluid. (The smell was HORRIBLE). After getting through with that (about 15 minutes), he wretched up more thick mucus with a few flecks of black cells in it. After awhile, he felt okay enough to go back to sleep.  Around 6am, he had another major allergy-like attack, but did not vomit.  Around 8am, after being awake for awhile, he vomited again with more black liquid, about 50mL this time. He felt weak and horrible and was shaking. At the recommendation of the advice nurse, he was taken to the ER by ambulance. Upon arriving, he waited around an hour for an ER bed.  They put him on an IV, did a physical inspection and did blood work. His sodium was a bit low, but in normal range. Potassium levels were fine. He was mentally clear the whole time, but physically very weak.  He was kept overnight after a hemochrit test in the afternoon showed low levels of hemoglobin. He was stabilized in the morning, but was barely able to eat anything the whole time. He was meant to get an endoscopy, but they decided to allow him to eat and sent him home after noon bc they hadn't yet been able to schedule him for it and he was in pain and massively hungry.  When he got home, he still barely ate,  and still isn't eating almost anything a day later. His stool was incredibly black and thick and SMELLY immediately upon arriving home (he had not defecated for 48 hours at that point), and he has not been able to defecate since, which is extremely abnormal (he usually goes each day in the morning upon waking).  They believe that he may have bleeding in his stomach or upper GI or esophagus, but we are waiting for an endoscopy later this week.  He is still very weak and frail and fatigued.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2014, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 09-AUG-2016, the patient was treated by a physician for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles "for the long-term prevention of shingles," the patient "suffered painful injuries and damages, and required extensive medical care and treatment." As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events is unknown. Additional information has been requested.
Fever, headache, chills, muscle pain all over,  joint pain, general malaise
Information has been received from a pharmacist via a company representative referring to a patient of unknown age and gender. The patient's concurrent conditions, concomitant medication and medical history were not provided. On unspecified dates, the patient received two doses of ZOSTAVAX (lot #, dose and route were unspecified). No adverse effect was reported. Additional information has been requested.
Unusual bouts of shortness of breath lasting between 5 minutes and one hour. Tightness in the chest. Typically, before being vaccinated, I only used my rescue inhaler a few times a month, but I?ve had to use it four times a day since the symptoms started after I received the second dose of the covid vaccine. Three days ago I even went to immediate care to get tested for Covid, got an x-ray of my lungs and an EKG, but all the results were normal. My oxygen level is 98, but the bouts of shortness of breath and tightness in the chest  continue to occur a few times a day, and during those episodes i feel like I cannot get a good breath even though my oxygen level remains high. Between these bouts, I feel fine. The doctors that met with me in the immediate care clinic thought this is likely a reaction to the Pfizer covid 19 vaccine, since all the tests came back normal. I have and echocardiogram and a chest CT scheduled in early May, but I will try to get these tests sooner.  I do not have the typical side effects of the vaccine, such as fever, body aches, headache or nausea. I do not have rashes or swelling of lymph nodes. Episodes of shortness of breath that are sometimes accompanied by tightness in my chest are my only symptoms. I have had COPD and asthma for decades, and these bouts feel different to me. My rescue inhaler does not always work when one of these episodes happens. I am not having difficulty walking or climbing stairs, except during one of these attacks. On the average i experience between two to four of these episodes per day.
Redness, swelling, pain at site. Pt feverish starting about 4 hours after shot. Symptoms lasted about 12 hours and were slighty improved after taking Tylenol.
Patient had no adverse events during the observation period after vaccine. He was conscious and having conversation with facility staff. He was observed for 15 minutes at least. When the facility staff returned later, approximately 60 to 90 minutes, patient had passed away.
Shortly after getting vaccines he was walking out and talking without any complaints except for soreness in thigh.  Fell straight back in mid sentence, eyes open and unresponsive for about 30 seconds.  Was unable to say where he was for about 3 minutes after becoming responsive.  Fell straight back onto floor, hitting head.  Complained of pain and pressure at back of head and nausea.  Shaking.  Stayed at pediatrician's office for about 45 minutes, ice applied to back of head.  He was still complaining of nausea and falling asleep, so took to Hospital Emergency Room.  He was given anti-nausea medication.  Diagnosed with a concussion.
EVERY PART OF MY BODY HURT ESPECIALLY MY HIPS, KNEES, NECK, HEAD, INJECTION SITE & NAUSEA BEGINNING DAY AFTER INJECTION & LASTED 3 DAYS.  SORE THROAT AND CHEST TIGHTNESS, PALPITATIONS, FATIGUE, INABILITY TO CATCH BREATH AND UNABLE TO CLEAR MY THROAT HAS NOT GONE AWAY!!!!!!
The evening of oct. 1 started feeling ill with symptoms of headache. vomited in the middle of the night and had some diarrhea. extremely nausea all the next day, body aches, weak couldn't lift arms up. starting to fill better but still not 100 percent
Low grade fever (100.2), body aches, lethargy, headache, soreness at injection site throughout the day on 3/21. Headache remains this morning (3/22).
Gave vaccine at 15:00, started clearing throat immediately in our car. Went home; no difficulty breathing or wheezing. Gave Benadryl. Said throat hurt; got better after Benadryl. At 20:00 was giving bath; noticed itchy rash--raised on abdomen/neck flat. Called MD on call. Told to give 25mg Benadryl. Rash resolved. No other problems.
pt recv vax 1APR97 & on 21AUG97 pt devel chickenpox that consisted of 40 lesions;
On 04/17/2019, nine days after receiving the SHINGRIX vaccine, I developed a rash on the left side of my back, which was diagnosed by my physician as shingles. I was prescribed valacyclovir.
Patient received a non Moderna vaccine as the second dose, instead the Moderna vaccine used in the 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Patient received a non Moderna vaccine as the second dose, instead the Moderna vaccine used in the 1st dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 17-Jul-2021, the patient started TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jul-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Patient received a non Moderna vaccine as the second dose, instead the Moderna vaccine used in the 1st dose). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Patient received a non Moderna vaccine as the second dose, instead the Moderna vaccine used in the 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient took Moderna vaccine as first dose 28 days ago the date she took Pfizer vaccine as second dose.  No concomitant medication was reported by reporter.  No treatment medication was reported by reporter.   Reporter did not allow further contact
Diagnosed with COVID-19 after Moderna COVID-19 vaccine (approximatelly five months after vaccination; Diagnosed with COVID-19 after Moderna COVID-19 vaccine and was experiencing respiratory symptoms and chest pressure; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with COVID-19 after Moderna COVID-19 vaccine and was experiencing respiratory symptoms and chest pressure) and DRUG INEFFECTIVE (Diagnosed with COVID-19 after Moderna COVID-19 vaccine (approximatelly five months after vaccination) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, the patient experienced COVID-19 (Diagnosed with COVID-19 after Moderna COVID-19 vaccine and was experiencing respiratory symptoms and chest pressure). On an unknown date, the patient experienced DRUG INEFFECTIVE (Diagnosed with COVID-19 after Moderna COVID-19 vaccine (approximatelly five months after vaccination). At the time of the report, COVID-19 (Diagnosed with COVID-19 after Moderna COVID-19 vaccine and was experiencing respiratory symptoms and chest pressure) and DRUG INEFFECTIVE (Diagnosed with COVID-19 after Moderna COVID-19 vaccine (approximatelly five months after vaccination) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2021, SARS-CoV-2 test: positive (Positive) Diagnosed with COVID-19 last week.         Patient went to the ER where treated with an experimental IV cocktail and was discharged to rest and quarantine at home. No concomitant medications were reported.
Instant pain on injection site that stayed/progressed for over a year until just recently saw improvement.  Fatigue and overall weakness - tried many different medications in following months for anxiety/depression thinking that was the issue as I continued to get worse  Severe brain fog/memory issues began impacting me at work, mental health treatment did more harm than good over next several months Severe nausea - daily, sometimes twice daily throwing up - tested for SIBO and treated with Rifaximin, did not feel improvement. Tried nortrypteline for nerve pain as I was in constant pain. Helped me sleep but felt unfamiliar anger and constipation on med so discontinued MIGRAINES - nothing really offered for this??? light sensitivity  NYSTAGMUS - not always severe but never an issue before vaccine, when I'm really stressed it's painfully obvious my eyes are darting back and forth and I usually am in pain all over when in this state Anxiety, depression worsen in severity  Quickly gained weight despite not changing eating habits Muscular weakness Shortness of breath/chest pain - went from averaging 8k+ steps a day to having to use a ride share to work because within weeks i was too exhausted to make the five minute walk to the train station and the other 7 minute walk to work. I was in constant pain and only went to work and came home to bed.  Told I have treatment resistant depression.
Diarrhea from the second day after the vaccine until today. Blurred vision.  Numbness of the face and arms. Pain in legs and feet. Headache.
Received IPV+DTaP in left leg 5/10/04. Onset redness and pain 5/11/04. On 5/12/04 redness, pain, heat and swelling to left lateral thigh. 14cmx17cm. Dr suspects reaction to pertussus.
606 doses were given after expiration date; Vaccine is placed in refrigerator 17 Nov 2021, expired product date on 03 Oct 2021, administration date on 29 Nov 2021; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine is placed in refrigerator 17 Nov 2021, expired product date on 03 Oct 2021, administration date on 29 Nov 2021) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Nov-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine is placed in refrigerator 17 Nov 2021, expired product date on 03 Oct 2021, administration date on 29 Nov 2021). On 29-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine is placed in refrigerator 17 Nov 2021, expired product date on 03 Oct 2021, administration date on 29 Nov 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant information was reported. Vaccine was placed in refrigerator on 17-Nov-2021. Vaccine did not undergone any temperature excursion. No  adverse events were reported for patient. No Treatment information was reported.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Nausea-Severe, Systemic: Vomiting-Severe, Additional Details: Patient stated she had only had bread that day. Her mom stated that she usually has issues like this with shots